HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Zemplar (paricalcitol injection)

TERMINATED · PHASE4 · End-Stage Kidney Disease

Unknown stopping reason

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.